DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Piccart M, Hortobagyi GN, Campone M. et al.
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2dagger.
Ann Oncol 2014;
25: 2357-2362
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.